Access to Medicinal Cannabis Regulations 2016

Authorised by the Chief Parliamentary Counsel Authorised Version i Access to Medicinal Cannabis Regulations 2016 S.R. No. 118/2016 TABLE OF PROVISIONS Regulation Page 1 Objective 1 2 Authorising provision 2 3 Commencement 2 4 Definition 2 5 Contract with Resources Secretary for activities under manufacturing authorisation 2 6 Contract with Health Secretary for activities under manufacturing authorisation 2 7 Person or body from whom Health Secretary may obtain or purchase medicinal cannabis product 2 8 Information for each product on approved medicinal cannabis product register 3 9 Information for practitioner medicinal cannabis authorisations register 3 10 Information for patient medicinal cannabis access authorisation 4 ═══════════════ -- 1 of 6 -- Authorised by the Chief Parliamentary Counsel Authorised Version 1 STATUTORY RULES 2016 S.R. No. 118/2016 Access to Medicinal Cannabis Act 2016 Access to Medicinal Cannabis Regulations 2016 The Governor in Council makes the following Regulations: Dated: 27 September 2016 Responsible Minister: JILL HENNESSY Minister for Health ANDREW ROBINSON Clerk of the Executive Council 1 Objective The objective of these Regulations is to prescribe— (a) activities that may be performed in contracts entered into under section 15 or 18 of the Access to Medicinal Cannabis Act 2016; and (b) persons and bodies from whom the Health Secretary may obtain or purchase medicinal cannabis products; and (c) information that is to be kept on the approved medicinal cannabis product register; and (d) information that is to be kept on the practitioner medicinal cannabis authorisations register; and -- 2 of 6 -- Access to Medicinal Cannabis Regulations 2016 S.R. No. 118/2016 2 Authorised by the Chief Parliamentary Counsel (e) information to be specified in a patient medicinal cannabis access authorisation. 2 Authorising provision These Regulations are made under section 100 of the Access to Medicinal Cannabis Act 2016. 3 Commencement These Regulations come into operation on 28 September 2016. 4 Definition In these Regulations— the Act means the Access to Medicinal Cannabis Act 2016. 5 Contract with Resources Secretary for activities under manufacturing authorisation For the purposes of section 15 of the Act, each activity referred to in section 14 of the Act is prescribed. 6 Contract with Health Secretary for activities under manufacturing authorisation For the purposes of section 18 of the Act, each activity referred to in section 17 of the Act is prescribed. 7 Person or body from whom Health Secretary may obtain or purchase medicinal cannabis product For the purposes of section 39(a)(ii) of the Act, a person or body who, under the law of another jurisdiction, is licensed or otherwise authorised to provide or sell a medicinal cannabis product is prescribed. -- 3 of 6 -- Access to Medicinal Cannabis Regulations 2016 S.R. No. 118/2016 3 Authorised by the Chief Parliamentary Counsel 8 Information for each product on approved medicinal cannabis product register For the purposes of section 41(3) of the Act, the following information is prescribed— (a) the name of the approved medicinal cannabis product; (b) the name of the manufacturer of the product; (c) the name and quantity of each of the product's active ingredients; (d) the form of the product (for example, whether it is in tablet or tincture form). 9 Information for practitioner medicinal cannabis authorisations register (1) For the purposes of section 53(2) of the Act, the following information is prescribed in respect of each entry for a practitioner medicinal cannabis authorisation— (a) the patient or participant in respect of whom the authorisation is issued; (b) the registered medical practitioner to whom the authorisation is issued; (c) the other registered medical practitioners authorised under the authorisation (if any); (d) the medicinal cannabis product or class of product in respect of which the authorisation is issued; (e) the date on which the authorisation was issued; (f) the date on which the authorisation expires; -- 4 of 6 -- Access to Medicinal Cannabis Regulations 2016 S.R. No. 118/2016 4 Authorised by the Chief Parliamentary Counsel (g) the details of each amendment made to the authorisation under section 54 of the Act; (h) the details of each suspension or cancellation of the authorisation under section 55 of the Act. (2) For the purposes of section 53(2) of the Act, the following information is prescribed in respect of each registered medical practitioner specified in a practitioner medicinal cannabis authorisation as authorised to issue a patient medicinal cannabis access authorisation— (a) the practitioner's name; (b) each of the practitioner's qualifications specified in the application for the practitioner medicinal cannabis authorisation; (c) each recognised specialty (within the meaning of the Health Practitioner Regulation National Law) in which the practitioner is registered; (d) the unique identifier given to the practitioner under section 233(2) of the Health Practitioner Regulation National Law. 10 Information for patient medicinal cannabis access authorisation For the purposes of section 57(2)(c) of the Act, the following information is prescribed in respect of a patient medicinal cannabis access authorisation— (a) the patient or participant's date of birth; (b) the patient or participant's medical condition or symptoms; -- 5 of 6 -- Access to Medicinal Cannabis Regulations 2016 S.R. No. 118/2016 5 Authorised by the Chief Parliamentary Counsel (c) in the case of a patient medicinal cannabis access authorisation issued in respect of a patient referred to in paragraph (a) of the definition of eligible patient in section 3 of the Act, the patient's height and weight. ═══════════════ -- 6 of 6 --